文献速递主动脉疾病

深低温停循环用于降主动脉及胸腹主动脉瘤修复的结局

Outcomes of Deep Hypothermic Circulatory Arrest for Descending and Thoracoabdominal Aneurysm Repair.
PubMed 文献 · Ann Vasc Surg · 2024-08-07

DHCA组住院死亡12.4%,非DHCA组7.8%(差值95%CI -5%至14%);DHCA组重症监护室停留与住院时间更长;作者认为选择性使用DHCA安全有效,发病率与死亡率与非DHCA相当。

要点

  • DHCA组住院死亡12.4%,非DHCA组7.8%(差值95%CI -5%至14%)。
  • DHCA组重症监护室停留5.5天 vs 非DHCA组6天,住院19天 vs 12天,DHCA组更长。
  • 作者认为在开放降主动脉及胸腹主动脉瘤修复中选择性使用DHCA安全有效。

核心结论

  • 尽管重症监护室停留和住院时间更长,选择性使用DHCA在开放降主动脉和胸腹主动脉瘤修复中安全有效,发病率与死亡率与非DHCA相当。

研究设计与样本

  • 81例(38.8%)因近端阻断不可行或动脉瘤病变延伸至弓部而需DHCA,128例(61.2%)仅需远端转流。
  • 因DHCA患者存在内在病理差异,采用置信区间比较组间差异而非正式假设检验。

主要发现

  • DHCA组慢性夹层比例64.2% vs 非DHCA组43.8%(差值95%CI 6%至35%)。
  • DHCA组体重指数29.5±6.8 vs 非DHCA组27.2±6.6(差值95%CI 26%至421%)。
  • 非DHCA组中层退变比例31.3% vs DHCA组9.9%(差值95%CI -33%至-7%)。
  • DHCA组住院死亡10例(12.4%) vs 非DHCA组10例(7.8%)(差值95%CI -5%至14%)。
  • 非DHCA组10年生存率52.6%(95%CI 42.1%至65.7%),DHCA组48.3%(95%CI 40.3%至57.9%)。

关键数值与推荐

  • DHCA组重症监护室停留5.5天 vs 非DHCA组6天(差值95%CI 12%至410%),DHCA组长于非DHCA组。
  • DHCA组住院时间19天 vs 非DHCA组12天(差值95%CI 74%至470%),DHCA组长于非DHCA组。

临床怎么用

  • 作者认为在开放降主动脉和胸腹主动脉瘤修复中选择性使用DHCA是安全有效的。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Deep hypothermic circulatory arrest (DHCA) in patients undergoing descending thoracic (DTAA) or thoracoabdominal aortic aneurysm (TAAA) repair is associated with increased morbidity and mortality. We present our outcomes after open DTAA and TAAA repair with and without DHCA. METHODS: From 1999 to 2022, 81 (38.8%) patients undergoing DTAA or TAAA repair required DHCA because proximal cross-clamping was not feasible or aneurysmal pathology extended into the arch and 128 (61.2%) patients required only distal bypass. Because of intrinsic pathological differences in patients requiring DHCA, confidence intervals (CIs) were used to compare groups in lieu of formal hypothesis tests. RESULTS: DHCA patients had more chronic dissections (64.2% vs. 43.8%, 95% CI for difference: 6-35%) and higher body mass indices (29.5 ± 6.8 vs. 27.2 ± 6.6, CI: 26-421%). More non-DHCA patients had medial degeneration (9.9% vs. 31.3%, CI: -33 to -7%). There were 10 (12.4%) in-hospital deaths for the DHCA and 10 (7.8%) for the non-DHCA group (CI: -5 to 14%). Survival at 10 years was 52.6% (CI: 42.1-65.7%) for the non-DHCA group and 48.3% (CI: 40.3-57.9%) for the DHCA group. The only meaningful differences in postoperative outcomes were intensive care unit (5.5 days vs. 6 days, CI: 12-410%) and hospital stay (19 days vs. 12 days, CI: 74-470%), which were longer in the DHCA group. CONCLUSIONS: Despite longer intensive care unit and hospital length of stays, selective use of DHCA is safe and effective with comparable morbidity and mortality to non-DHCA in open DTAA and TAAA repair.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Chen JR, Shah VN, Koeneman SH, et al. Outcomes of Deep Hypothermic Circulatory Arrest for Descending and Thoracoabdominal Aneurysm Repair. Ann Vasc Surg. 2024. PMID: 39096955. doi:10.1016/j.avsg.2024.07.096

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。